MRSA

Jiang-Kun Dai1, Wen-Jia Dan2, Yi-Dan Cao2

  • 1State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Taipa, Macau SAR, China; School of Life Science and Technology, Weifang Medical University, Shandong, China.

PubMed
概括

一种新型诺哈曼衍生物,化合物5a,对抗抗甲素耐药黄金葡萄球菌 (MRSA) 感染表现出强烈的活性. 这种化合物在体外和体内表现出有效性,具有较低的耐药性发展趋势,提供了一个有前途的新疗法候选者.